Abstract
The aim of our study was to estimate brain perfusion and cognitive function (CF) in patients with arterial hypertension (AH) before and after hypotensive therapy. The study included 15 patients (mean age, 53.0±5.7 years) with previously untreated or ineffectively treated essential hypertension of the second degree. All patients underwent brain single photon emission computed tomography (SPECT) scanning with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO) and comprehensive neuropsychological testing before and after 24 weeks of hypotensive therapy (angiotensin-converting enzyme [ACE] inhibitor or diuretics). The brain perfusion was significantly lower (15–22%) in all regions of AH patients. These patients showed a 25% decrease in attention and psychomotor speed as well as a 14% decrease in mentation. Six months of hypotensive therapy led to an increase in brain perfusion by an average of 7–11% in all brain regions. After treatment these patients demonstrated an average 11–18% improvements in attention and psychomotor speed, as well as an average 10% improvement in abstract mentation. Marked signs of brain hypoperfusion and impaired CF: decrease in attention, slowing psychomotor speed and mentation was found in hypertensive patients even without focal neurological symptomatology. Twenty-four weeks of hypotensive treatment with ACE inhibitors or diuretics had a positive effect on cerebral perfusion and led to CF improvement.
Similar content being viewed by others
Article PDF
References
Birkenhäger WH, Forette F, Seux M-L, Wang JG, Staessen JA : Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med 2001; 161: 152–156.
Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA : Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36: 1079–1084.
Kilander L, Nyman H, Boberg M, Hansson L, Lithell H : Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31: 780–786.
Launer LJ, Masaki K, Petrovich H, Foley D, Havlik RJ : The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA 1995; 274: 1846–1851.
Skoog I, Lernfelt B, Landahl S, et al: Fifteen-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141–1145.
Chazova IE, Mychka VB, Gornostaev VV, Dvoskina IM, Sergienko VB : Cerebrovascular complication in patients with arterial hypertension: primary and secondary prophylaxis. Consilium Medicum 2003; 5 ( 2): 3–6.
Cutler NR, Sramek JJ, Luna A, et al: Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patients. Ann Pharmacother 1996; 30: 578–582.
Geraskina LA, Suslina ZA, Foniakin AV, Sharypova TN : Cerebral perfusion in patients with arterial hypertension and chronic forms of brain vascular pathology. Ter Arkh 2003; 75 ( 12): 32–36.
Mychka VB, Sergienko VB, Gornostaev VV, Dvoskina IM, Chazova IE : Inpact of bisoprolol therapy on brain perfusion in patients with metabolic syndrome. Arterial Hypertens (Moscow) 2003; 9 ( 5): 151–154.
Nobili F, Rodriguez G, Marenco S, et al: Regional cerebral blood flow in chronic hypertension. A correlative study. Stroke 1993; 24: 1148–1153.
Hansson L, Himmelmann A, Hedner T : Hypertension of dementia: can antihypertensive treatment preserve cognitive function? Blood Press 1999; 8: 196–197.
Goldstein G, Materson BJ, Cushman WC, et al: Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension 1990; 15: 361–369.
Lassen NA, Andersen AR, Fribrg L, Paulson OB : The retention of [99m-Tc]-d,l,-HMPAO in the human brain after intracarotid bolus injection: akinetic analysis. J Cereb Blood Flow Metab 1988; 8: 13–22.
Yonekura Y, Nishizawa S, Mukai T, et al: SPECT with 99m-Tc-d,l-hexamethylpropylene amine oxime (HM-PAO) compared with regional cerebral bloodflow measured by PET: effects of linearization. J Cereb Blood Flow Metab 1988; 8: 82–89.
Lezak MD : Neuropsychological Assessment. New York, Oxford University Press, 1995.
Wechsler D : Wechsler Memory Scale-Revised. Manual. New York, Psychological Corporation, 1987.
Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H : The microcirculation and hypertension. J Hypertens Suppl 1992; 10: S147–S156.
Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA : Microcirculation in hypertension: a new target for treatment? Circulation 2001; 104: 735–740.
Vicaut E : Hypertension and microcirculation: an overview of experimental studies. Medicographia 1999; 21: 34–40.
1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–183.
Bertel O, Marx B, Conen D : Effects of antihypertensive treatment on cerebral perfusion. Am J Med 1987; 7: 82–92.
Meyer JS, Rogers RL, Mortel RF : Prospective analysis of long-term control of mild hypertension in cerebral blood flow. Stroke 1985; 16: 985–990.
Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lusardi P : β-Blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 1999; 33: 534–539.
Oku N, Kitagawa K, Imaizumi M, et al: Hemodynamic influences of losartan on the brain in hypertensive patients. Hypertens Res 2005; 28: 43–49.
Frohlich ED : Local hemodynamic changes in hypertension: insights for therapeutic preservation of target organs hypertension. Hypertension 2001; 38: 1388–1394.
Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A : Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. Neurology 1999; 53: 1948–1952.
Knopman D, Boland LL, Mosley T, et al: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42–48.
Kalra L, Jackson S, Swift C : Effect of antihypertensive treatment on psychomotor performance in the elderly. J Hum Hypertens 1993; 7: 285–290.
Ostroumova OD, Korsakova NK, Bagramova YuA, Varko NA : Arterial hypertension and vascular dementia: influence of hypotensive therapy on cognitive function in older patients (clinical and pharmacoeconomical aspects). Consilium Medicum 2003; 5: 18–21.
Seux M-L, Forette F : Effects of hypertension and its treatment on mental function. Curr Hypertens Rep 1999; 1: 232–237.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Efimova, I., Efimova, N., Triss, S. et al. Brain Perfusion and Cognitive Function Changes in Hypertensive Patients. Hypertens Res 31, 673–678 (2008). https://doi.org/10.1291/hypres.31.673
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.673
Keywords
This article is cited by
-
Intracranial baroreflex is attenuated in an ovine model of renovascular hypertension
Scientific Reports (2021)
-
Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study))
Pilot and Feasibility Studies (2015)
-
Regional Cerebral Blood Flow and Arterial Blood Volume and Their Reactivity to Hypercapnia in Hypertensive and Normotensive Rats
Journal of Cerebral Blood Flow & Metabolism (2014)
-
Blood Pressure and Cognitive Outcome
Current Cardiovascular Risk Reports (2010)